Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review

被引:455
作者
Zhao, Chuang [1 ]
Rakesh, K. P. [1 ]
Ravidar, L. [1 ]
Fang, Wan-Yin [1 ]
Qin, Hua-Li [1 ]
机构
[1] Wuhan Univ Technol, Sch Chem Chem Engn & Life Sci, Dept Pharmaceut Engn, 205 Luoshi Rd, Wuhan 430070, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
Sulfonyl (S-VI); Sulfonamides; SAR; Docking; Biological activities; CARBONIC-ANHYDRASE INHIBITORS; STRUCTURE-BASED DESIGN; BEARING BENZENE SULFONAMIDE; TARGET-DIRECTED LIGANDS; HIV PROTEASE INHIBITORS; IN-VITRO EVALUATION; BIOLOGICAL EVALUATION; ALZHEIMERS-DISEASE; MOLECULAR DOCKING; 5-HT6; RECEPTOR;
D O I
10.1016/j.ejmech.2018.11.017
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Sulfur (S-VI) based moieties, especially, the sulfonyl or sulfonamide based analogues have showed a variety of pharmacological properties, and its derivatives propose a high degree of structural diversity that has established useful for the finding of new therapeutic agents. The developments of new less toxic, low cost and highly active sulfonamides containing analogues are hot research topics in medicinal chemistry. Currently, more than 150 FDA approved Sulfur (S-VI)-based drugs are available in the market, and they are widely used to treat various types of diseases with therapeutic power. This comprehensive review highlights the recent developments of sulfonyl or sulfonamides based compounds in huge range of therapeutic applications such as antimicrobial, anti-inflammatory, antiviral, anticonvulsant, antitubercular, antidiabetic, antileishmanial, carbonic anhydrase, antimalarial, anticancer and other medicinal agents. We believe that, this review article is useful to inspire new ideas for structural design and developments of less toxic and powerful Sulfur (S-VI) based drugs against the numerous death-causing diseases. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:679 / 734
页数:56
相关论文
共 251 条
[1]  
Aadil A., 2016, J MOL STRU, V1117, P269
[2]   Synthesis and biological evaluation of cyclic imides incorporating benzenesulfonamide moieties as carbonic anhydrase I, II, IV and IX inhibitors [J].
Abdel-Aziz, Alaa A. -M. ;
Angeli, Andrea ;
El-Azab, Adel S. ;
Abu El-Enin, Mohamed A. ;
Supuran, Claudiu T. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (05) :1666-1671
[3]   New 1,2-diaryl-4-substituted-benzylidene-5-4H-imidazolone derivatives: Design, synthesis and biological evaluation as potential anti-inflammatory and analgesic agents [J].
Abdellatif, Khaled R. A. ;
Fadaly, Wael A. A. .
BIOORGANIC CHEMISTRY, 2017, 72 :123-129
[4]   Synthesis, characterization, biological activities and molecular modeling of Schiff bases of benzene sulfonamides bearing curcumin scaffold [J].
Ahmed, Mahmood ;
Qadir, Muhammad Abdul ;
Shafiq, Muhammad Imtiaz ;
Muddassar, Muhammad ;
Samra, Zahoor Qadir ;
Hameed, Abdul .
ARABIAN JOURNAL OF CHEMISTRY, 2019, 12 (01) :41-53
[5]   Development and biological evaluation of 99mTc-sulfonamide derivatives for in vivo visualization of CA IX as surrogate tumor hypoxia markers [J].
Akurathi, Vamsidhar ;
Dubois, Ludwig ;
Celen, Sofie ;
Lieuwes, Natasja G. ;
Chitneni, Satish K. ;
Cleynhens, Bernard J. ;
Innocenti, Alessio ;
Supuran, Claudiu T. ;
Verbruggen, Alfons M. ;
Lambin, Philippe ;
Bormans, Guy M. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 71 :374-384
[6]   Designing Anti-inflammatory Drugs from Parasitic Worms: A Synthetic Small Molecule Analogue of the Acanthocheilonema viteae Product ES-62 Prevents Development of Collagen-Induced Arthritis [J].
Al-Riyami, Lamyaa ;
Pineda, Miguel A. ;
Rzepecka, Justyna ;
Huggan, Judith K. ;
Khalaf, Abedawn I. ;
Suckling, Colin J. ;
Scott, Fraser J. ;
Rodgers, David T. ;
Harnett, Margaret M. ;
Harnett, William .
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (24) :9982-10002
[7]   Resistance to antibiotics: Are we in the post-antibiotic era? [J].
Alanis, AJ .
ARCHIVES OF MEDICAL RESEARCH, 2005, 36 (06) :697-705
[8]   Type 2 diabetes in the young: The evolving epidemic - The International Diabetes Federation Consensus Workshop [J].
Alberti, G ;
Zimmet, P ;
Shaw, J ;
Bloomgarden, Z ;
Kaufman, F ;
Silink, M .
DIABETES CARE, 2004, 27 (07) :1798-1811
[9]   Discovery of HIV-1 protease inhibitors with picomolar affinities incorporating N-aryl-oxazolidinone-5-carboxamides as novel P2 Ligands [J].
Ali, Akbar ;
Reddy, G. S. Kiran Kumar ;
Cao, Hong ;
Anjum, Saima Ghafoor ;
Nalam, Madhavi N. L. ;
Schiffer, Celia A. ;
Rana, Tariq M. .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (25) :7342-7356
[10]   Structure-Based Design, Synthesis, and Structure-Activity Relationship Studies of HIV-1 Protease Inhibitors Incorporating Phenyloxazolidinones [J].
Ali, Akbar ;
Reddy, G. S. Kiran Kumar ;
Nalam, Madhavi N. L. ;
Anjum, Saima Ghafoor ;
Cao, Hong ;
Schiffer, Celia A. ;
Rana, Tariq M. .
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (21) :7699-7708